The CL7 Affinity Tag System
Our CL7/Im7 system continues to be validated by research groups around the world as they apply our purification framework to their area of study.
Our novel method has been tested and verified for activity in difficult-to-purify proteins such as those that are DNA/RNA binding, eukaryotic, membrane, toxic, or multi-subunit.
Read more below about how we and other groups have adopted the CL7 tag purification system in numerous studies.
Protein Expression and Purification
TriAltus Bioscience holds the exclusive, worldwide license to the CL7 protein purification technology platform. It was licensed from the University of Alabama at Birmingham (UAB) in Birmingham, Alabama, USA. An international patent filing has been made with protection being sought in the United States, Europe, and other major markets. The CL7 purification technology is available for research use. For commercial use or resale, contact us at sales@trialtusbioscience.